9:30 AM
From Pilot to Practice: How Health Systems Evaluate and Integrate AI Models Using Continuous Real-World Feedback
Meg Columbia Walsh, Managing Director, Oberon Securities
10:00 AM
Evidence-Informed AI Development: Designing Models Around Real-World Burden of Disease and Unmet Clinical Needs
Hamid Tabatabaie, CEO, CodaMetrix
10:35 AM
Networking BREAK
11:00 AM
Practical Applications and Operations of AI in Healthcare
Meg Columbia Walsh, Managing Director, Oberon Securities
Jennifer Brown, Speaker & Author, Jennifer Speaks
12:00 PM
What Moves the Needle? The Evidence Investors and Payers Demand Before Backing or Buying Health AI Solutions
Prem Sreenivasan, Senior Fellow, HITLAB
12:30 PM
LUNCH
1:30 PM
Building Patient Trust Through Evidence: Communicating AI Risks, Benefits, and Outcomes in Accessible Language
Representative, Decimal.Health
2:00 PM
The Role of Consent in Evidence Generation: How Opt-In AI Studies Can Improve Trust and Outcomes
Dive into the evolving landscape of digital consent and patient participation—highlighting how proactive, opt-in approaches to AI validation can improve generalizability, accountability, and transparency in AI research.
Representative, Floreo
2:30 PM
NETWORKING BREAK
3:00 PM
Imaging AI at Scale: What the Evidence Shows on Diagnostic Accuracy, Time Savings, and Clinical Decision Impact
Review the latest data from health systems deploying imaging AI at population scale—evaluating its impact on diagnostic efficiency, workflow throughput, and downstream care quality across specialties.
Amy West, Principal, Advisory Services & Chair Women’s Global Health Tech Initiative, HITLAB
3:30 PM
What Makes a Health System AI-Ready? The Role of Governance, Workforce, and Evidence Pathway
Alexia Priest, Director, Business Development, HITLAB